Jose Octavio Pinto Costa Filho - 12 Jul 2021 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Medical Officer
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
Issuer symbol
MNPR
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
13 Jul 2021, 16:35:31 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +91,500 $0.000000 91,500 12 Jul 2021 Common Stock 91,500 $5.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter.